Copeptin: Utility in Paediatric Patients with Hyponatraemia
Rachel L Boal1, James Hughes1, Debbie Matthews1
1Department of Pediatric Endocrinology, Great North Children's Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
Insights
Copeptin levels can help diagnose the cause of hyponatraemia in children, particularly in cases of syndrome of inappropriate antidiuretic hormone and Schaaf-Yang syndrome. While not immediately guiding treatment, copeptin clarifies vasopressin regulation mechanisms.
Area of Science:
- Pediatric Endocrinology
- Clinical Chemistry
- Genetics
Background:
- Copeptin is a biomarker for vasopressin, useful in diagnosing polyuria/polydipsia in children.
- Its role in pediatric hyponatraemia (low sodium) requires further clarification.
Observation:
- Five pediatric cases of hyponatraemia were analyzed.
- Elevated copeptin in four cases suggested syndrome of inappropriate antidiuretic hormone (SIADH).
- One case involved Schaaf-Yang syndrome with variable copeptin levels.
Findings:
- Elevated copeptin (13.7-233 pmol/L) indicated SIADH in most hyponatraemic children.
- Low copeptin ruled out SIADH as a cause of hyponatraemia and oliguria in one patient.
- Schaaf-Yang syndrome showed dysregulated vasopressin with fluctuating copeptin.
Implications:
- Copeptin measurement aids in understanding the pathophysiology of pediatric hyponatraemia.
- It helps differentiate causes like SIADH and genetic conditions.
- While not acutely altering management, it provides crucial diagnostic insight into vasopressin dysregulation.
Introduction:
Copeptin concentrations are a useful component of the diagnostic workup of paediatric patients with polyuria and polydipsia, but the value of measuring copeptin in patients with hyponatraemia is less clear.
Case Reports:
We report 5 children with hyponatraemia in the context of different underlying pathologies. Copeptin concentrations were elevated in 4 cases (13.7, 14.4, 26.1, and 233 pmol/L; reference range 2.4-8.6 pmol/L), suggesting that non-osmoregulated vasopressin release (syndrome of inappropriate antidiuretic hormone) was the underlying mechanism for low sodium levels. In one of the patients, there was an underlying diagnosis of Schaaf-Yang syndrome (MAGEL2 gene mutation) with a clinical picture suggestive of dysregulated vasopressin production with inappropriately high and then low copeptin release. In one hyponatraemic patient, low copeptin concentrations indicated that non-osmoregulated arginine vasopressin release was not the cause of hyponatraemia and oliguria.
Discussion:
Copeptin measurement did not influence management acutely but helped to clarify the mechanism leading to hyponatraemia when the result was available. Relatively high and low copeptin concentrations in association with hypo- and hypernatraemia indicate dysregulated vasopressin production in Schaaf-Yang syndrome.
More Related Videos
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Acute Kidney Injury V: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption


